The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study
Chelsea Xu(University of California, San Francisco), Jennifer C. Lai(University of California, San Francisco), Michael A. Dunn(University of Pittsburgh Medical Center), Dorry L. Segev(Johns Hopkins Medicine), Yara Mohamad(University of California, San Francisco), Elizabeth C. Verna(Universität Hamburg), Matthew R. Kappus(Duke University), Monica A. Tincopa(University of California San Diego), Daniel Ganger(Northwestern University), Andrés Duarte‐Rojo(University of Pittsburgh Medical Center), Joshua D. Grab(University of California, San Francisco), Brian J. Boyarsky(Johns Hopkins University), Robert S. Rahimi(Baylor University), Mara McAdams‐DeMarco(Johns Hopkins University), Michael L. Volk(Loma Linda University), Daniela P. Ladner(Northwestern University)
Cited by 33
Related Papers
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2021|629
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
|New England Journal of Medicine|2017|565
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
|Annals of Internal Medicine|2018|295